Ligand Pharmaceuticals
LGND
$70.46
Share price
-0.16%
Change (1 day)
-8.16%
Change (1 year)
EPS for Ligand Pharmaceuticals (LGND)
EPS in 2023 (TTM): $1.57
According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $1.57. In 2022 the company made an earnings per share (EPS) of -$1.98 a decrease over its 2021 EPS that were of $3.46.
EPS history for Ligand Pharmaceuticals from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $1.57 | -179.29% |
| 2022 | -$1.98 | -157.23% |
| 2021 | $3.46 | -2571.43% |
| 2020 | -$0.14 | -100.46% |
| 2019 | $30.61 | 353.48% |
| 2018 | $6.75 | 1025% |
| 2017 | $0.60 | -700% |
| 2016 | -$0.10000 | -100.87% |
| 2015 | $11.56 | 1859.32% |
| 2014 | $0.59 | 5.36% |
| 2013 | $0.56 | 8.0704505322479E+18% |
| 2012 | $0.0000000000 | -100% |
| 2011 | $0.49 | -194.23% |
| 2010 | -$0.52 | 548.38% |
| 2009 | -$0.08020 | -98.7% |
| 2008 | -$6.18 | -136.52% |
| 2007 | $16.92 | -787.8% |
| 2006 | -$2.46 | -14.58% |
| 2005 | -$2.88 | -21.31% |
| 2004 | -$3.66 | -55.15% |
| 2003 | -$8.16 | 81.33% |
| 2002 | -$4.50 | 2.74% |
| 2001 | -$4.38 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | 797.15% | 🇺🇸 USA |
 Pfizer PFE | $1.86 | 18.47% | 🇺🇸 USA |
 Eli Lilly LLY | $5.43 | 245.81% | 🇺🇸 USA |
 Amgen AMGN | $14.15 | 801.27% | 🇺🇸 USA |
 Baxter BAX | $5.12 | 226.11% | 🇺🇸 USA |
 Merck MRK | $1.82 | 16.03% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.97 | 152.87% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $3.50 | 122.98% | 🇬🇧 UK |
 Spectrum Pharmaceuticals
SPPI | -$0.36 | -122.93% | 🇺🇸 USA |